Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Will Work for Reward: Effects of Ghrelin Administration on Dopamine and Effort
NCT05318924Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Feb 2022
- Primary completion
- Aug 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human ghrelin in major depressive disorder (MDD), sponsored by University Hospital Tübingen. Started Feb 2022; status: completed.
02
Drugs
human ghrelin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05318924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318924.